P. FRACH, D. GLÖSS, M. VERGÖHL, K. HUND-RINKE, I. TRICK, Physikalisch-chemische und mikrobiologische Wirkung gesputterter photokatalytischer Titanoxid-Schichten, Vakuum in Forschung und Praxis 19 (2007) Nr. 6 20-27 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

R. KLEEMANN, A. HAUSSER, G. GEIGER , R. MISCHKE, A. BURGER-KENTISCHER, O. FLIEGER, FJ. JOHANNES, T. ROGER, T. CALANDRA, A. KAPURNIOTU, M. GRELL, D. FINKELMEIER, H. BRUNNER, J. BERNHAGEN, Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1, Nature 408: 211-216 (2000).

A. BURGER-KENTISCHER, H. GOEBEL, R. SEILER, G. FRAEDRICH, H.E. SCHAEFER, S. DIMMELER, R. KLEEMANN, J. BERNHAGEN, C. IHLING, Expression of Macrophage Migration Inhibitory Factor in different stages of human Atherosclerosis. Circulation 105: 1561-1566 (2002).

A. BURGER-KENTISCHER, D. FINKELMEIER, M. THIELE, J. SCHMUCKER, G. GEIGER, G. TOVAR, J. BERNHAGEN, Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif. FEBS Lett. 14;579(7):1693-701 (2005).

A. BURGER-KENTISCHER, H. GOEBEL, R. KLEEMANN, A. ZERNECKE, R. BUCALA, L. LENG, D. FINKELMEIER, G. GEIGER, HE. SCHAEFER, A. SCHOBER, C. WEBER, H. BRUNNER, H. RUTTEN, C. IHLING, J. BERNHAGEN, Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis 184:28-38 (2006)

C. OEHR, D. HEGEMANN, M. MÜLLER, U. VOHRER, M. STORR, Rf-Plasma Treatment on the Inside of Small Functional Devices for Biomedical Application, Plasma Processes and Polymers, Eds. R. d `Agostino. P. Favia, C. Oehr, M.R. Wertheimer, Wiley-VCH, Weinheim 309-317 (2005)

C. OEHR, Plasma surface modification of polymers for biomedical use, Nuclear Instruments and methods in Physics Research B, 208:40-47 (2003)

S. ZANINI, M. MÜLLER, C. RICCARDI, M. ORLANDI, Polyethylene Glycol Grafting on Polypropylene Membranes for Antifouling Properties, Plasma Chem. Plasma Process, 27: 446-457 (2007)